Task: Answer the multiple-choice question.
Question: Which drug exhibits a 3.275\% hERG inhibition at 1uM?
Constraint: You must select none, one or more options from a, b, or c without using any other words.
Options:
(a) CCOc1cccc(Nc2ccc([N+](=O)[O-])cn2)c1
(b) CCOc1ccccc1C1C(C(N)=O)=C(C)Nc2nc(-c3ccccc3Cl)nn21
(c) Cc1cc(OC(C)C(=O)NCCCN2CCOCC2)c2c(C)c(C)c(=O)oc2c1
Answer: c. Cc1cc(OC(C)C(=O)NCCCN2CCOCC2)c2c(C)c(C)c(=O)oc2c1
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_1uM#}{herg_central_at_1uM__units} {herg_central_at_1uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_1uM%}
Answer: {%multiple_choice_result}. {SMILES#}
Cc1cc(OC(C)C(=O)NCCCN2CCOCC2)c2c(C)c(C)c(=O)oc2c1
Cc1cc(OC(C)C(=O)NCCCN2CCOCC2)c2c(C)c(C)c(=O)oc2c1
N-(3-morpholin-4-ylpropyl)-2-(3,4,7-trimethyl-2-oxochromen-5-yl)oxypropanamide